Multidisciplinary approach in the management of advanced ovarian cancer patients : a personalized approach. Results from a specialized ovarian cancer unit
Articolo
Data di Pubblicazione:
2017
Citazione:
Multidisciplinary approach in the management of advanced ovarian cancer patients : a personalized approach. Results from a specialized ovarian cancer unit / G.D. Aletti, A. Garbi, P.F. Messori, M.T. Achilarre, V. Zanagnolo, S. Rizzo, S. Alessi, L. Bocciolone, F. Landoni, R. Biffi, S. Carinelli, N. Colombo, A. Maggioni. - In: GYNECOLOGIC ONCOLOGY. - ISSN 0090-8258. - 144:3(2017), pp. 468-473. [10.1016/j.ygyno.2017.01.017]
Abstract:
Objective The aim of the present study was to evaluate the impact of a multidisciplinary approach in patients' selection with advanced ovarian cancer (AOC) for different therapeutic strategies. Methods Patients referred at our institution between 2009 and 2012 for AOC were included. Primary multidisciplinary evaluation was performed in all patients. Different strategies included: 1. patients referred to primary neoadjuvant chemotherapy (NACT) and interval surgery (IDS) (group A); 2. patients considered for surgical exploration. After surgical exploration, patients were either considered for primary debulking (PDS; group B), or NACT (group C). Results A total of 363 patients were included. Of 38 patients (10.5%) in group A, 24 (63%) had sovradiaphragmatic/multiple liver metastases; 14 (37%) were excluded for PDS for anestehesiologic/medical reasons. Of 325 (89.5%) considered for surgical exploration, 295 (91%; group B) had primary surgery with debulking intent (N: 277) and were cytoreduced to no macroscopic disease (R0: N:200; 68%) o minimal RD < 5 mm (R1: N:77; 26%) or palliative intent (N:18; 6%); 30 (9%; group C) were referred for NACT. Of those, 27 (90%) underwent IDS, 3 had progressive disease. Overall survival (OS) and progression free survival (PFS) was different between the groups: OS: Group A: 34 months; Group B: 59 months; Group C: 29 months; p < 0.001. PFS: Group A: 10 months; Group B; 21 months; Group C: 12 months; p < 0.001. Conclusions A multidisciplinary approach to patients referred to a tertiary center with AOC allows optimization of the treatment strategy, based on patients' characteristics (age, performance/nutritional status, comorbidities, functional status) and tumor diffusion (evaluated pre- and intraoperatively).
Tipologia IRIS:
01 - Articolo su periodico
Keywords:
Oncology; Obstetrics and Gynecology
Elenco autori:
G.D. Aletti, A. Garbi, P.F. Messori, M.T. Achilarre, V. Zanagnolo, S. Rizzo, S. Alessi, L. Bocciolone, F. Landoni, R. Biffi, S. Carinelli, N. Colombo, A. Maggioni
Link alla scheda completa: